Sanford Burnham Prebys is a 501(c)(3) non-profit medical research institute focusing on basic and translational research, with major research programs in cancer, neurodegeneration, diabetes, infectious, inflammatory, and childhood diseases. The institute also specializes in stem cell research and drug discovery technologies.
|President and CEO||David Brenner, M.D.|
|Budget||$109 million (FY2021)|
|Address||10901 North Torrey Pines Road|
The Institute employs more than 500 scientists and staff at its campus in La Jolla, California. It is recognized for its NCI-designated Cancer Center, its drug discovery center (Conrad Prebys Center for Chemical Genomics) and the Sanford Children’s Health Research Center. It also has strategic partnerships with the biotech and pharmaceutical industry.
Sanford Burnham Prebys operates an NCI-designated Cancer Center (one of seven basic research centers in the U.S.) and is ranked in the top 2% of research institutions worldwide by the number of citations. It is also #6 in the nation for the Nature Index of nonprofit/non-government institutions in biomedical science.
Since its inception in 1976, the institute has grown from a small building in West San Diego to a campus in La Jolla including an accredited graduate school with more than 350 postdocs, graduate students and interns mentored per year. Current Institute educational programs serve trainees with professional development programs, postdoctoral scientific training and graduate programs in Biomedical Sciences. The Sanford Burnham Prebys educational system partners with the Sanford Burnham Prebys Science Network, the Office of Education, Training & International Services to cover an array of scientific career and professional development topics.
Oops something went wrong: